Neo Kuma Ventures
Startups
Psychedelics startups are on a long journey to consumer markets, but these 5 VCs are taking the ride
9:09 am PDT • May 4, 2022
Previously relegated to underground communities and raves, ketamine, MDMA and psilocybin are now being studied to develop therapies to treat everything from PTSD to cluster headaches.